Skip to main content
. 2024 Mar 27;82:44. doi: 10.1186/s13690-024-01275-8

Table 2.

OR (95% CI) in frailty associated with log-urinary heavy metals levels according to multivariate logistic regression

Urine Metals (log-µg/g creatinine) Model 1 Model 2 Model 3
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Cadmium
 Continuous 2.13 (1.79, 2.55) < 0.01 1.55 (1.29, 1.87) < 0.01 1.90 (1.51, 2.40) < 0.01
 Q1 Reference Reference Reference
 Q2 1.28 (1.07, 1.52) 0.01 1.15 (0.96, 1.39) 0.13 1.23 (1.01, 1.51) 0.04
 Q3 1.40 (1.18, 1.67) < 0.01 1.16 (0.97, 1.39) 0.11 1.25 (1.01, 1.54) 0.04
 Q4 1.97 (1.66, 2.34) < 0.01 1.47 (1.23, 1.76) < 0.01 1.71 (1.37, 2.14) < 0.01
P for trend 2.54 (2.02, 3.19) < 0.01 1.69 (1.33, 2.16) < 0.01 2.06 (1.53, 2.78) < 0.01
Cobalt
 Continuous 1.49 (1.29, 1.71) < 0.01 1.39 (1.20, 1.61) < 0.01 1.64 (1.40, 1.93) < 0.01
 Q1 Reference Reference Reference
 Q2 0.89 (0.75, 1.05) 0.17 0.84 (0.70, 1.00) 0.05 0.99 (0.81, 1.20) 0.91
 Q3 1.04 (0.87, 1.23) 0.69 0.94 (0.79, 1.13) 0.52 1.22 (1.00, 1.49) 0.05
 Q4 1.42 (1.21, 1.68) < 0.01 1.25 (1.05, 1.49) 0.01 1.77 (1.45, 2.15) < 0.01
P for trend 2.12 (1.60, 2.81) < 0.01 1.73 (1.28, 2.34) < 0.01 3.02 (2.16, 4.22) < 0.01
Cesium
 Continuous 0.73 (0.66, 0.81) < 0.01 0.73 (0.65, 0.81) < 0.01 0.93 (0.82, 1.04) 0.20
 Q1 Reference Reference Reference
 Q2 0.81 (0.69, 0.95) 0.01 0.84 (0.70, 0.99) 0.04 1.03 (0.86, 1.25) 0.72
 Q3 0.68 (0.58, 0.80) < 0.01 0.69 (0.58, 0.82) < 0.01 0.89 (0.74, 1.08) 0.25
 Q4 0.63 (0.53, 0.74) < 0.01 0.62 (0.51, 0.74) < 0.01 0.89 (0.73, 1.10) 0.28
P for trend 0.69 (0.61, 0.78) < 0.01 0.68 (0.60, 0.78) < 0.01 0.90 (0.77, 1.04) 0.16
Molybdenum
 Continuous 1.01 (0.95, 1.08) 0.71 0.97 (0.90, 1.03) 0.29 1.04 (0.97, 1.12) 0.31
 Q1 Reference Reference Reference
 Q2 1.00 (0.84, 1.18) 0.97 0.91 (0.77, 1.09) 0.32 0.97 (0.80, 1.17) 0.72
 Q3 1.05 (0.88, 1.24) 0.60 0.94 (0.79, 1.13) 0.52 1.03 (0.85, 1.24) 0.79
 Q4 1.14 (0.96, 1.34) 0.14 0.99 (0.83, 1.18) 0.89 1.18 (0.97, 1.43) 0.10
P for trend 1.07 (0.99, 1.16) 0.11 1.00 (0.92, 1.09) 0.99 1.09 (0.99, 1.19) 0.08
Antimony
 Continuous 1.22 (0.71, 2.09) 0.48 0.89 (0.50, 1.59) 0.70 1.13 (0.60, 2.12) 0.70
 Q1 Reference Reference Reference
 Q2 1.11 (0.94, 1.32) 0.23 1.03 (0.86, 1.23) 0.74 1.06 (0.88, 1.29) 0.53
 Q3 1.27 (1.07, 1.50) 0.01 1.17 (0.98, 1.40) 0.08 1.26 (1.04, 1.53) 0.02
 Q4 1.39 (1.18, 1.65) < 0.01 1.22 (1.03, 1.46) 0.03 1.39 (1.15, 1.69) < 0.01
P for trend 9.79 (3.14, 30.56) < 0.01 4.38 (1.33, 14.46) 0.02 10.95 (2.96, 40.44) < 0.01
Thallium
 Continuous 0.20 (0.12, 0.33) < 0.01 0.24 (0.14, 0.40) < 0.01 0.58 (0.34, 1.01) 0.06
 Q1 Reference Reference Reference
 Q2 0.61 (0.51, 0.71) < 0.01 0.61 (0.52, 0.73) < 0.01 0.70 (0.59, 0.85) < 0.01
 Q3 0.54 (0.46, 0.64) < 0.01 0.56 (0.47, 0.67) < 0.01 0.69 (0.57, 0.83) < 0.01
 Q4 0.50 (0.42, 0.59) < 0.01 0.53 (0.44, 0.63) < 0.01 0.72 (0.59, 0.88) < 0.01
P for trend 0.08 (0.04, 0.15) < 0.01 0.10 (0.05, 0.20) < 0.01 0.33 (0.15, 0.73) 0.01
Tungsten
 Continuous 1.75 (1.23, 2.49) < 0.01 1.74 (1.20, 2.52) < 0.01 1.96 (1.32, 2.92) < 0.01
 Q1 Reference Reference Reference
 Q2 1.17 (0.98, 1.40) 0.08 1.16 (0.97, 1.39) 0.11 1.14 (0.94, 1.39) 0.19
 Q3 1.55 (1.31, 1.85) < 0.01 1.49 (1.25, 1.78) < 0.01 1.44 (1.19, 1.75) < 0.01
 Q4 1.60 (1.35, 1.90) < 0.01 1.57 (1.31, 1.87) < 0.01 1.57 (1.29, 1.90) < 0.01
P for trend 9.00 (4.12, 19.65) < 0.01 8.10 (3.59, 18.29) < 0.01 8.45 (3.46, 20.65) < 0.01
Uranium
 Continuous 11.27 (2.39, 53.27) < 0.01 9.09 (2.03, 40.63) 0.00 7.84 (1.63, 37.59) 0.01
 Q1 Reference Reference Reference
 Q2 1.26 (1.06, 1.51) 0.01 1.20 (1.00, 1.43) 0.05 1.12 (0.92, 1.36) 0.26
 Q3 1.41 (1.18, 1.67) < 0.01 1.20 (1.01, 1.44) 0.04 1.13 (0.93, 1.38) 0.22
 Q4 1.57 (1.32, 1.86) < 0.01 1.34 (1.12, 1.60) < 0.01 1.34 (1.10, 1.63) < 0.01
P for trend 3273357.52 (6473.41, inf.) < 0.01 8803.56 (12.25, 6326095.72) 0.01 43188.09 (32.09, inf.) < 0.01

Model 1: crude model;

Model 2: adjusted for age, sex, race, family income-poverty ratio, and education;

Model 3: adjusted for age, sex, race, family income-poverty ratio, education, smoking status, alcohol intake, serum cotinine concentration, BMI, hypertension, diabetes, physical activity and eGFR.

Abbreviation: Q: quartile